Stockscreener 앱 받기
276.67
0.54%
-1.50
시간 외 거래:
276.67
전일 마감가:
$278.17
열려 있는:
$277.6
하루 거래량:
1.64M
Relative Volume:
0.58
시가총액:
$41.78B
수익:
$4.39B
순이익/손실:
$853.00M
주가수익비율:
50.22
EPS:
5.5097
순현금흐름:
$556.00M
1주 성능:
-5.80%
1개월 성능:
+34.01%
6개월 성능:
+128.79%
1년 성능:
+194.77%
1일 변동 폭
$268.52
$278.00
1주일 범위
$254.00
$309.35
52주 변동 폭
$88.00
$309.35
일루미나 Stock (ILMN) Company Profile
명칭
Illumina Inc
전화
(858) 202-4500
주소
5200 ILLUMINA WAY, SAN DIEGO, CA
Compare ILMN vs TMO, DHR, NTRA, A, IQV
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ILMN
Illumina Inc
|
276.67 | 41.78B | 4.39B | 853.00M | 556.00M | 5.5097 |
TMO
Thermo Fisher Scientific Inc
|
662.24 | 244.86B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
221.20 | 155.50B | 24.78B | 3.68B | 5.29B | 5.1743 |
NTRA
Natera Inc
|
397.77 | 57.34B | 2.50B | -226.32M | 71.51M | -1.6412 |
A
Agilent Technologies Inc
|
171.33 | 48.30B | 7.23B | 1.41B | 1.09B | 4.979 |
IQV
Iqvia Holdings Inc
|
262.21 | 43.16B | 16.63B | 1.39B | 2.12B | 8.0674 |
일루미나 Stock (ILMN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-09-09 | 재개 | UBS | Buy |
| 2026-06-26 | 재개 | Bernstein | Mkt Perform |
| 2026-06-10 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2026-05-15 | 재개 | RBC Capital Mkts | Outperform |
| 2026-05-14 | 업그레이드 | Daiwa Securities | Neutral → Outperform |
| 2025-08-12 | 다운그레이드 | Daiwa Securities | Outperform → Neutral |
| 2025-07-11 | 다운그레이드 | Scotiabank | Sector Outperform → Sector Perform |
| 2025-03-04 | 재확인 | Citigroup | Neutral |
| 2025-02-28 | 다운그레이드 | HSBC Securities | Buy → Hold |
| 2025-02-10 | 다운그레이드 | Barclays | Equal Weight → Underweight |
| 2025-02-07 | 다운그레이드 | TD Cowen | Buy → Hold |
| 2024-12-11 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2024-11-12 | 재개 | Morgan Stanley | Equal-Weight |
| 2024-10-17 | 업그레이드 | HSBC Securities | Hold → Buy |
| 2024-08-28 | 업그레이드 | Argus | Hold → Buy |
| 2024-08-16 | 업그레이드 | Daiwa Securities | Neutral → Buy |
| 2024-08-14 | 업그레이드 | Barclays | Underweight → Equal Weight |
| 2024-08-14 | 업그레이드 | TD Cowen | Hold → Buy |
| 2024-07-10 | 업그레이드 | Citigroup | Neutral → Buy |
| 2024-06-03 | 재개 | Jefferies | Hold |
| 2024-01-16 | 다운그레이드 | HSBC Securities | Buy → Hold |
| 2024-01-04 | 다운그레이드 | TD Cowen | Outperform → Market Perform |
| 2023-12-18 | 업그레이드 | Scotiabank | Sector Perform → Sector Outperform |
| 2023-12-15 | 업그레이드 | Bernstein | Underperform → Mkt Perform |
| 2023-12-14 | 개시 | Guggenheim | Buy |
| 2023-12-14 | 개시 | Stephens | Overweight |
| 2023-12-13 | 개시 | Wolfe Research | Outperform |
| 2023-12-12 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2023-12-11 | 업그레이드 | Citigroup | Sell → Neutral |
| 2023-11-10 | 다운그레이드 | Canaccord Genuity | Buy → Hold |
| 2023-09-28 | 개시 | Bernstein | Underperform |
| 2023-07-05 | 재개 | JP Morgan | Neutral |
| 2023-01-25 | 다운그레이드 | Argus | Buy → Hold |
| 2023-01-05 | 개시 | Scotiabank | Sector Perform |
| 2022-12-12 | 다운그레이드 | Citigroup | Neutral → Sell |
| 2022-12-07 | 개시 | RBC Capital Mkts | Outperform |
| 2022-10-04 | 업그레이드 | SVB Leerink | Mkt Perform → Outperform |
| 2022-09-28 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2022-08-25 | 개시 | Credit Suisse | Neutral |
| 2022-07-13 | 다운그레이드 | Barclays | Equal Weight → Underweight |
| 2022-01-18 | 업그레이드 | Stifel | Hold → Buy |
| 2022-01-11 | 업그레이드 | Barclays | Underweight → Equal Weight |
| 2022-01-07 | 업그레이드 | BofA Securities | Underperform → Neutral |
| 2022-01-06 | 재개 | Morgan Stanley | Equal-Weight |
| 2022-01-06 | 재개 | Piper Sandler | Overweight |
| 2021-10-15 | 재개 | Cowen | Outperform |
| 2021-08-19 | 다운그레이드 | SVB Leerink | Outperform → Mkt Perform |
| 2021-06-01 | 업그레이드 | Evercore ISI | Underperform → In-line |
| 2021-03-31 | 다운그레이드 | Atlantic Equities | Overweight → Neutral |
| 2021-03-31 | 업그레이드 | Canaccord Genuity | Hold → Buy |
| 2021-03-03 | 개시 | Barclays | Underweight |
| 2020-12-22 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2020-12-17 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2020-10-13 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2020-09-30 | 개시 | Atlantic Equities | Overweight |
| 2020-09-29 | 다운그레이드 | Wolfe Research | Outperform → Peer Perform |
| 2020-09-22 | 다운그레이드 | Stifel | Buy → Hold |
| 2020-09-22 | 다운그레이드 | UBS | Buy → Neutral |
| 2020-09-21 | 업그레이드 | Guggenheim | Neutral → Buy |
| 2020-09-21 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2020-09-09 | 개시 | Morgan Stanley | Equal-Weight |
| 2020-08-07 | 다운그레이드 | Evercore ISI | In-line → Underperform |
| 2020-08-07 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2020-07-07 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2020-04-24 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2020-04-21 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2020-01-08 | 개시 | Wells Fargo | Underweight |
| 2020-01-07 | 개시 | Citigroup | Buy |
| 2020-01-02 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2019-11-15 | 개시 | Stifel | Buy |
| 2019-10-25 | 개시 | Guggenheim | Buy |
모두보기
일루미나 주식(ILMN)의 최신 뉴스
Introducing SpliceAI2: The Next Generation of Splicing and Transcript Isoform Prediction - Illumina
Illumina Inc (ILMN) Stock Up 5.1% but GF Value Says Overvalued -- GF Score: 65/100 - GuruFocus
Illumina Inc. stock outperforms competitors on strong trading day - MarketWatch
Illumina, Inc. Stock 12‑Month Price Target Raised to $237.16, Implies 10% Downside - TradingView
What is Illumina’s (ILMN) Economic Moat, and is it Widening or Narrowing? - Yahoo Finance
Illumina to Announce Third Quarter 2026 Financial Results on Thursday, October 29, 2026 - Investing News Network
Illumina, Inc. Initiates Recall of NovaSeq 6000Dx Including DRAGEN Server And Illumina DRAGEN Server For NextSeq 550Dx - www.marketscreener.com
Illumina Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Illumina to Announce Third Quarter 2026 Financial Results on Thursday, October 29, 2026 - Illumina
Illumina releases SpliceAI2 to help advance rare disease research - PR Newswire
After shares were delivered or withheld for exercise price or tax liability, Illumina (ILMN) CEO holds 107,770 shares. - Stock Titan
Illumina Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
She transformed genomics. Multiomics is next: The Sequence - Illumina
With voting power over 15.4M shares, FMR reports a passive stake in Illumina (ILMN). - Stock Titan
Global Microfluidics Market by Product Type, Application, End User, and Region, 2026-2036 | $48.04 Billion Opportunity Driven by Point-of-Care Diagnostics and Automation - GlobeNewswire Inc.
RBC raises target for Illumina stock to USD 310 - AD HOC NEWS
Illumina (ILMN) Shares Skyrocket, What You Need To Know - Yahoo Finance
Illumina (ILMN) Shares Skyrocket, What You Need To Know - FinancialContent
Illumina Inc. stock outperforms competitors on strong trading day - MarketWatch
Illumina stock gains 7.95 percent as RBC raises target - AD HOC NEWS
Illumina Inc Stock (ILMN) Moved Up by 7.85% on Oct 5: Drivers Behind the Movement - TradingKey
Illumina rises as recent analyst target hikes and index inclusion keep momentum intact - Quiver Quantitative
Illumina stock hits 52-week high at 280.44 USD By Investing.com - Investing.com South Africa
Illumina stock hits 52-week high at 280.44 USD - Investing.com
Illumina's Clinical Sequencing Revenue Seen as Durable Mid-Teens Grower, RBC Capital Markets Says - marketscreener.com
Illumina's Clinical Sequencing Revenue Seen as Durable Mid-Teens Grower, RBC Capital Markets Says - Yahoo Finance
RBC Capital raises Illumina stock price target on clinical sales - Investing.com
RBC Capital maintains Outperform rating on Illumina, $310 price target - TradingView
RBC raises target for Illumina stock to USD 310 - AD HOC NEWS
Illumina Inc : RBC Raises Target Price to $31 - Moomoo
Immunogenomics Market Size, Share, Trends, and Growth Forecast, 2026-2033 | NGS and Personalized Medicine Drive Market Toward USD 9.82 Billion at 5.97% CAGR - GlobeNewswire Inc.
Form 4 Illumina Inc For: 2 October By Investing.com - Investing.com South Africa
A director receives 107 shares instead of cash for quarterly retainer fees at Illumina (ILMN). - Stock Titan
A director receives stock for 100% of Q3 retainer fees at Illumina (ILMN) - Stock Titan
Illumina Inc. stock outperforms competitors on strong trading day - MarketWatch
Illumina Inc. stock outperforms competitors on strong trading day - MarketWatch
Illumina, Inc. (ILMN) Stock Forecasts - Yahoo Finance
Illumina Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Global Liver Cancer Diagnostics Market to Observe Impressive Growth at a CAGR of ~9% by 2034 | DelveInsight - GlobeNewswire Inc.
3 Reasons to Buy Grail (GRAL) Hand Over Fist in October - The Motley Fool
The Benchmark Matters: Evaluating TruPath Genome Beyond Individual Loci - Illumina
Where Will Illumina Stock Be in 5 Years If Its AI Bet Pays Off? - The Motley Fool
REGN or ILMN: Which Is the Better Value Stock Right Now? - Zacks Investment Research
Is the Options Market Predicting a Spike in Illumina Stock? - Yahoo Finance
Illumina Inc. stock underperforms Friday when compared to competitors - MarketWatch
Illumina stock adds 3.20 percent ahead of the open - AD HOC NEWS
Will Index Reshuffle Change Illumina (ILMN) Narrative - simplywall.st
Illumina Inc. stock outperforms competitors on strong trading day - MarketWatch
Here's How Much $1000 Invested In Illumina 20 Years Ago Would Be Worth Today - Benzinga
Illumina stock holds near its yearly high as targets diverge - AD HOC NEWS
일루미나 (ILMN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
일루미나 주식 (ILMN) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Corvex Management LP | Affiliate of Director (1) |
Sep 04 '26 |
Proposed Sale |
213.25 |
150,000 |
31,987,500 |
0 |
| Meister Keith A. | Director |
Sep 03 '26 |
Sale |
218.23 |
75,951 |
16,574,481 |
889,851 |
| Meister Keith A. | Director |
Sep 02 '26 |
Sale |
213.28 |
68,108 |
14,526,254 |
965,802 |
| Corvex Management LP | Affiliate of Director (1) |
Aug 27 '26 |
Proposed Sale |
224.84 |
200,000 |
44,968,000 |
0 |
| Meister Keith A. | Director |
Aug 27 '26 |
Sale |
228.89 |
138,379 |
31,673,778 |
1,033,910 |
| Meister Keith A. | Director |
Aug 26 '26 |
Sale |
225.46 |
106,543 |
24,021,247 |
1,172,289 |
| Corvex Management LP | Affiliate of Director (1) |
Aug 25 '26 |
Proposed Sale |
223.22 |
300,000 |
66,966,000 |
0 |
| Meister Keith A. | Director |
Aug 25 '26 |
Sale |
225.51 |
131,019 |
29,546,639 |
1,278,832 |
| Meister Keith A. | Director |
Aug 21 '26 |
Sale |
217.96 |
299,336 |
65,243,445 |
1,409,851 |
| Corvex Management LP | Affiliate of Director (1) |
Aug 21 '26 |
Proposed Sale |
213.24 |
250,000 |
53,310,000 |
0 |
1.15%
0.38%
자본화:
|
볼륨(24시간):